HR5027-118

Introduced

To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes.

118th Congress Introduced Jul 27, 2023

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Transportation, Technology.

Who Benefits and How

health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section H8671446DE7EF49D89B28B928EFBF6CC3: 1. Short title; table of contents This Act may be cited as the Chronic Kidney Disease Improvement in Research and Treatment Act of 2023.
  • Section H81483EAD7BDA49C49E6FFDA7219F5FC0: 101. Expanding medicare annual wellness benefit to include kidney disease screening Section 1861(ww)(2) of the Social Security Act (42 U.S.C. 1395x(ww)(2)) is...
  • Section H39C3477A1B824865BFC5D6A67DEF43D0: 102. Increasing access to medicare kidney disease education benefit Section 1861(ggg) of the Social Security Act (42 U.S.C. 1395x(ggg)) is amended— in...
  • Section H80D75E8FF5FC41A8AD07191C1FE1E3C7: 201. Refining the end-stage renal disease payment system to improve accuracy in payment and support therapies Section 1881(b)(14) of the Social Security Act...
  • Section HE46665B994CC49DB9855905B37B9A7A7: 202. Ensuring medicare advantage supports kidney care innovative therapies Section 1853(c) of the Social Security Act (42 U.S.C. 1395ww–23(c)) is amended by...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.

Key Policy Areas

Healthcare, Transportation, Technology

Primary Purpose

This bill, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.

Policy Domains

Healthcare Transportation Technology

Whole bill

Identified Gains
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
health care providers and patients: ,
Identified Costs
  • federal implementing agencies
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal implementing agencies: ,
health care providers and patients: ,

Legislative Progress

Introduced
Introduced Committee Passed
Jul 27, 2023

Mrs. Miller of West Virginia (for herself and Ms. Sewell) …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Transportation Technology
Actor Mappings
"secretary_of_health_and_human_services"
→ Secretary of Health and Human Services

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology